Enhancing myeloablative fludarabine-busulfan conditioning with total marrow irradiation in high-risk myeloid disease2026-01-010 OA AI FF Molina AAlberto Mussetti AAnna Sureda * DOI:10.3324/haematol.2025.288307OriginalOriginal request for helpShareSaveAbstract En